Avenue Therapeutics Stock to Reverse Split on Friday, April 26th (NASDAQ:ATXI)

Avenue Therapeutics, Inc. (NASDAQ:ATXI)’s stock is going to reverse split on the morning of Friday, April 26th. The 1-75 reverse split was announced on Friday, April 26th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, April 26th.

Avenue Therapeutics Stock Performance

NASDAQ:ATXI traded down $0.04 on Wednesday, hitting $0.09. 12,284,611 shares of the stock were exchanged, compared to its average volume of 4,543,282. The stock has a market capitalization of $4.17 million, a price-to-earnings ratio of -0.07 and a beta of -0.24. Avenue Therapeutics has a 52 week low of $0.09 and a 52 week high of $1.25. The company’s 50-day moving average price is $0.15 and its 200 day moving average price is $0.21.

Avenue Therapeutics (NASDAQ:ATXI) last announced its quarterly earnings data on Monday, March 18th. The company reported $0.56 earnings per share for the quarter.

About Avenue Therapeutics

Avenue Therapeutics, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders.